Literature DB >> 23553574

Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs.

Renata Rizzo, Mariangela Gulisano, Paola V Calì, Alfredo Di Pino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23553574     DOI： 10.1007/s00787-013-0413-y

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  15 in total

1.  Long QT Syndromes.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

2.  Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.

Authors:  Junzo Watanabe; Yutaro Suzuki; Naoki Fukui; Shin Ono; Takuro Sugai; Nobuto Tsuneyama; Toshiyuki Someya
Journal:  J Clin Psychopharmacol       Date:  2012-02       Impact factor: 3.153

3.  The cost-effectiveness of drug regulation: the example of thorough QT/QTc studies.

Authors:  J C Bouvy; M A Koopmanschap; R R Shah; H Schellekens
Journal:  Clin Pharmacol Ther       Date:  2011-12-28       Impact factor: 6.875

Review 4.  Assessing QT interval prolongation and its associated risks with antipsychotics.

Authors:  Jimmi Nielsen; Claus Graff; Jørgen K Kanters; Egon Toft; David Taylor; Jonathan M Meyer
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

5.  Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome.

Authors:  Mariangela Gulisano; Paola V Calì; Andrea E Cavanna; Clare Eddy; Hugh Rickards; Renata Rizzo
Journal:  Neurol Sci       Date:  2011-07-06       Impact factor: 3.307

6.  Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study.

Authors:  Christoph U Correll; Jennifer Harris; Vicki Figen; John M Kane; Peter Manu
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-08-08       Impact factor: 2.576

7.  Arrhythmic risk in congenital long QT syndrome.

Authors:  Elizabeth S Kaufman
Journal:  J Electrocardiol       Date:  2011-09-09       Impact factor: 1.438

8.  In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol.

Authors:  A Sugiyama; Y Satoh; K Hashimoto
Journal:  Toxicol Appl Pharmacol       Date:  2001-06-01       Impact factor: 4.219

Review 9.  Antipsychotic drugs and QT interval prolongation.

Authors:  Wojciech Zareba; David A Lin
Journal:  Psychiatr Q       Date:  2003

Review 10.  A review of the safety and tolerability of aripiprazole.

Authors:  Chi-Un Pae
Journal:  Expert Opin Drug Saf       Date:  2009-05       Impact factor: 4.250
View more
  3 in total

1.  Pharmacological Intervention in Children with Autism Spectrum Disorder with Standard Supportive Therapies Significantly Improves Core Signs and Symptoms: A Single-Center, Retrospective Case Series.

Authors:  Hamza A Alsayouf; Haitham Talo; Marisa L Biddappa; Mohammad Qasaymeh; Shadi Qasem; Emily De Los Reyes
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-16       Impact factor: 2.570

2.  Core Signs and Symptoms in Children with Autism Spectrum Disorder Improved after Starting Risperidone and Aripiprazole in Combination with Standard Supportive Therapies: A Large, Single-Center, Retrospective Case Series.

Authors:  Hamza A Alsayouf; Haitham Talo; Marisa L Biddappa
Journal:  Brain Sci       Date:  2022-05-09

3.  Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study.

Authors:  Hamza A Alsayouf; Haitham Talo; Marisa L Biddappa; Emily De Los Reyes
Journal:  Children (Basel)       Date:  2021-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.